Evaluating the effect of healthcare providers on the clinical path of heart failure patients through a semi-Markov, multi-state model.


Journal

BMC health services research
ISSN: 1472-6963
Titre abrégé: BMC Health Serv Res
Pays: England
ID NLM: 101088677

Informations de publication

Date de publication:
12 Jun 2020
Historique:
received: 16 04 2020
accepted: 05 05 2020
entrez: 14 6 2020
pubmed: 14 6 2020
medline: 26 11 2020
Statut: epublish

Résumé

Investigating similarities and differences among healthcare providers, on the basis of patient healthcare experience, is of interest for policy making. Availability of high quality, routine health databases allows a more detailed analysis of performance across multiple outcomes, but requires appropriate statistical methodology. Motivated by analysis of a clinical administrative database of 42,871 Heart Failure patients, we develop a semi-Markov, illness-death, multi-state model of repeated admissions to hospital, subsequent discharge and death. Transition times between these health states each have a flexible baseline hazard, with proportional hazards for patient characteristics (case-mix adjustment) and a discrete distribution for frailty terms representing clusters of providers. Models were estimated using an Expectation-Maximization algorithm and the number of clusters was based on the Bayesian Information Criterion. We are able to identify clusters of providers for each transition, via the inclusion of a nonparametric discrete frailty. Specifically, we detect 5 latent populations (clusters of providers) for the discharge transition, 3 for the in-hospital to death transition and 4 for the readmission transition. Out of hospital death rates are similar across all providers in this dataset. Adjusting for case-mix, we could detect those providers that show extreme behaviour patterns across different transitions (readmission, discharge and death). The proposed statistical method incorporates both multiple time-to-event outcomes and identification of clusters of providers with extreme behaviour simultaneously. In this way, the whole patient pathway can be considered, which should help healthcare managers to make a more comprehensive assessment of performance.

Sections du résumé

BACKGROUND BACKGROUND
Investigating similarities and differences among healthcare providers, on the basis of patient healthcare experience, is of interest for policy making. Availability of high quality, routine health databases allows a more detailed analysis of performance across multiple outcomes, but requires appropriate statistical methodology.
METHODS METHODS
Motivated by analysis of a clinical administrative database of 42,871 Heart Failure patients, we develop a semi-Markov, illness-death, multi-state model of repeated admissions to hospital, subsequent discharge and death. Transition times between these health states each have a flexible baseline hazard, with proportional hazards for patient characteristics (case-mix adjustment) and a discrete distribution for frailty terms representing clusters of providers. Models were estimated using an Expectation-Maximization algorithm and the number of clusters was based on the Bayesian Information Criterion.
RESULTS RESULTS
We are able to identify clusters of providers for each transition, via the inclusion of a nonparametric discrete frailty. Specifically, we detect 5 latent populations (clusters of providers) for the discharge transition, 3 for the in-hospital to death transition and 4 for the readmission transition. Out of hospital death rates are similar across all providers in this dataset. Adjusting for case-mix, we could detect those providers that show extreme behaviour patterns across different transitions (readmission, discharge and death).
CONCLUSIONS CONCLUSIONS
The proposed statistical method incorporates both multiple time-to-event outcomes and identification of clusters of providers with extreme behaviour simultaneously. In this way, the whole patient pathway can be considered, which should help healthcare managers to make a more comprehensive assessment of performance.

Identifiants

pubmed: 32532254
doi: 10.1186/s12913-020-05294-3
pii: 10.1186/s12913-020-05294-3
pmc: PMC7291648
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

533

Subventions

Organisme : Medical Research Council
ID : MC_UU_00002/11
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00002/5
Pays : United Kingdom

Références

Med Decis Making. 2008 May-Jun;28(3):419-34
pubmed: 18480038
Stat Methods Med Res. 2017 Jun;26(3):1350-1372
pubmed: 25817136
PLoS One. 2017 Jun 7;12(6):e0179176
pubmed: 28591172
Lancet. 2004 Apr 3;363(9415):1147-54
pubmed: 15064036
Eur J Heart Fail. 2014 Jul;16(7):729-36
pubmed: 24806352
Int J Cardiol. 2015 Feb 15;181:81-7
pubmed: 25497525
Ann Intern Med. 1997 Oct 15;127(8 Pt 2):666-74
pubmed: 9382378
Stat Med. 2007 May 20;26(11):2389-430
pubmed: 17031868
Heart. 2006 Apr;92(4):503-6
pubmed: 16118240
Demography. 1979 Aug;16(3):439-54
pubmed: 510638
J R Stat Soc Ser C Appl Stat. 2018 Feb;67(2):481-500
pubmed: 29371746
Health Econ. 2018 Feb;27(2):e13-e27
pubmed: 28833902
PLoS One. 2014 Sep 11;9(9):e106494
pubmed: 25211034
Int Stat Rev. 2017 Aug;85(2):185-203
pubmed: 29307954
Stat Med. 2008 Apr 30;27(9):1351-70
pubmed: 17922491
Genet Epidemiol. 2003 Feb;24(2):139-49
pubmed: 12548675
Stat Methods Med Res. 2010 Oct;19(5):529-46
pubmed: 20488838
Stat Med. 1999 Mar 30;18(6):695-706
pubmed: 10204198
Arch Intern Med. 2002 Aug 12-26;162(15):1689-94
pubmed: 12153371
BMC Med Res Methodol. 2012 Jun 15;12:79
pubmed: 22702430
Heart. 2007 Sep;93(9):1137-46
pubmed: 17699180
Eur J Heart Fail. 2012 Feb;14(2):168-75
pubmed: 22158778
Biostatistics. 2018 Dec 26;:
pubmed: 30590499

Auteurs

Francesca Gasperoni (F)

MRC Biostatistics Unit, University of Cambridge, Forvie Site, Robinson Way, Cambridge, CB2 0SR, UK. francesca.gasperoni@mrc-bsu.cam.ac.uk.

Francesca Ieva (F)

MOX laboratory, Department of Mathematics, Politecnico di Milano, Piazza Leonardo da Vinci, 32, Milan, 20133, Italy.
CADS-Center for Analysis, Decisions and Society, Human Technopole, Via Cristina Belgioioso, 171, Milan, 20157, Italy.
CHRP-National Center for Healthcare Research and Pharmacoepidemiology, University of Milano-Bicocca, Via Bicocca degli Arcimboldi, 8, Milan, 20126, Italy.

Anna Maria Paganoni (AM)

MOX laboratory, Department of Mathematics, Politecnico di Milano, Piazza Leonardo da Vinci, 32, Milan, 20133, Italy.
CADS-Center for Analysis, Decisions and Society, Human Technopole, Via Cristina Belgioioso, 171, Milan, 20157, Italy.
CHRP-National Center for Healthcare Research and Pharmacoepidemiology, University of Milano-Bicocca, Via Bicocca degli Arcimboldi, 8, Milan, 20126, Italy.

Christopher H Jackson (CH)

MRC Biostatistics Unit, University of Cambridge, Forvie Site, Robinson Way, Cambridge, CB2 0SR, UK.

Linda Sharples (L)

Department of Medical Statistics, London School of Hygiene & Tropical Medicine, Keppel Street, London, WC1E 7HT, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH